CAR-T

Armored CAR T cells overcome tumor defenses in solid cancers News-Medical.Net21:46T-Cells Cancer UCLA

GC Cell seeks approval for China-licensed multiple myeloma CAR-T therapy Fucaso Korea Biomedical Review23:16Cancer Treatment Blood Cancer Biotechnology

Next-generation CAR T therapy offers hope but faces clinical challenges News-Medical.Net11:15Cancer Cancer Treatment

Gilead acquires CAR-T specialist Arcellx for $7.8bn Pharmaceutical Technology02:50T-Cells Cancer Cancer Treatment

Ultra-sensitive CAR T cells eliminate hard-to-treat tumours in mice Nature.com14:42T-Cells Nature

Gilead buys cell therapy partner Arcellx for up to $7.8bn pharmaphorum08:07Gilead Sciences Blood Cancer Pharma

Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion The Economic Times14:21Gilead Sciences Pharma Biotech

Poolbeg Pharma adds CAR-T therapy expert to scientific advisory board Proactive Investors (UK)03:36Biotechnology Pharma

Curocell’s Rimqarto achieves 1st confirmed 5-year cure in high-risk lymphoma Korea Biomedical Review00:57Cancer Cancer Treatment Blood Cancer

Stat Plus: Gilead to buy Arcellx in nearly $8B deal STAT06:08Gilead Sciences Biotechnology Pharma

Latest News

Yesterday

Poolbeg Pharma adds CAR-T therapy expert to scientific advisory board Proactive Investors (UK)03:36 12-Mar-26

In the last 7 days

Multiple Myeloma Awareness Month: the current and future landscape Pharmaceutical Technology12:33 6-Mar-26

In the last month

NexCure, Inc. Launches with $19 Million Series A Financing to enable CAR-T and other advanced… PR Newswire (Press Release)07:02 5-Mar-26

Armored CAR T cells overcome tumor defenses in solid cancers News-Medical.Net21:46 4-Mar-26

UCLA Researchers Engineer CAR-T Cells to Target Hard-to-Treat Solid Tumors Newswise (Press Release)14:03 4-Mar-26

Hematologic Malignancies Market to Reach USD 128.48 Billion by 2032, Driven by Immunotherapy,… PR Newswire (Press Release)14:38 3-Mar-26

Autoimmune CAR-T: Navigating the FDA’s new regulatory playbook FiercePharma07:55 27-Feb-26

GC Cell seeks approval for China-licensed multiple myeloma CAR-T therapy Fucaso Korea Biomedical Review23:16 26-Feb-26

Ultra-sensitive car T cells eliminate hard-to-treat tumours in mice Nature.com14:42 26-Feb-26

Eli Lilly acquires Orna Therapeutics for $2.4B to disrupt car-T market Bellingham Herald12:24 25-Feb-26

Next-generation CAR T therapy offers hope but faces clinical challenges News-Medical.Net11:15 25-Feb-26

Curocell’s Rimqarto achieves 1st confirmed 5-year cure in high-risk lymphoma Korea Biomedical Review00:57 25-Feb-26

AI to fuel biotech renaissance, says Anthropic CEO Dario Amodei The Financial Express13:30 24-Feb-26

Solving Cancer Immunotherapy’s Fuel Shortage Newswise (Press Release)10:56 24-Feb-26

OUH opens its first CAR-T therapy trial for multiple myeloma Oxford University Hospitals (Press Release)05:51 24-Feb-26

Gilead acquires CAR-T specialist Arcellx for $7.8bn Pharmaceutical Technology02:50 24-Feb-26

Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion The Economic Times14:21 23-Feb-26

Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical &… PR Newswire (Press Release)08:59 23-Feb-26

Gilead buys cell therapy partner Arcellx for up to $7.8bn pharmaphorum08:07 23-Feb-26

STAT Plus: Gilead to buy Arcellx in nearly $8B deal STAT06:08 23-Feb-26

Kymriah To Country Music: Prof. Bruce Levine’s Unwavering CAR-T Focus Scrip Pharma Intelligence05:30 20-Feb-26

Remote-controlled CAR T cells offer safer cancer therapy News-Medical.Net22:59 19-Feb-26

A remote-controlled CAR-T for safer immunotherapy Newswise (Press Release)12:25 19-Feb-26

Cellares and University of Wisconsin School of Medicine and Public Health Expand Partnership to … Business Wire (Press Release)09:05 18-Feb-26

The Center for Cancer and Blood Disorders Revolutionizes the Delivery of CAR-T Cancer… PR Newswire (Press Release)10:03 17-Feb-26

Researchers Develop “Smart” Gene Therapy That Targets and Destroys Cancer Cells Iraqi News Agency09:51 17-Feb-26

CARsgen invests RMB 370 M to expand CAR-T commercial manufacturing base in Shanghai BioSpectrum Asia01:49 14-Feb-26

Car-T therapy provides relief for children with autoimmune diseases Nature.com16:47 13-Feb-26

Prior Ibrutinib May Improve CAR-T Efficacy in Rare Lymphoma Medpage Today16:09 13-Feb-26

Car T-cell therapy may slow neurodegenerative conditions like Als New Scientist07:12 13-Feb-26

World-First EXO 001 Exosome Platform Enables In Vivo Multi-Target CAR-T for Solid Tumors PR Newswire (Press Release)02:31 13-Feb-26

Long-term follow-up demonstrates the curative potential of dual CD19/CD22 car-T-cell therapy alone or combined with… Nature.com20:12 12-Feb-26

CARsgen Signs Strategic Cooperation Agreements to Expand CAR-T Commercial Manufacturing Base in … PR Newswire (Press Release)19:20 12-Feb-26

Alzheimer’s plaques decline after CAR-T immune cell treatment in preclinical study News-Medical.Net18:27 11-Feb-26

From relapse to remission: What an indigenous car-T therapy signals for India’s cancer market The Hindu Business Line02:12 11-Feb-26

LLY Expands Cell Therapy Ambitions With $2.4B Orna Therapeutics Deal Zacks12:12 10-Feb-26

Gyala Therapeutics inicia un ensayo clínico de fase I/IIa de una terapia con células CAR-T PR Newswire (Press Release)06:04 10-Feb-26

Gyala Therapeutics startet Phase-I/IIa-Studie zu einer CAR-T-Zelltherapie bei akuten Leukämien… PR Newswire (Press Release)06:04 10-Feb-26

Gyala Therapeutics initiates Phase I/IIa clinical trial of a CAR-T cell therapy in acute… PR Newswire (Press Release)06:04 10-Feb-26

Lilly acquires car-T therapy biotech Orna Therapeutics for $2.4bn European Pharmaceutical Review05:54 10-Feb-26

view more headlines

12 Mar 03:36

About our CAR-T news

Latest news on CAR-T (Chimeric Antigen Receptor T-cell) therapy, a type of cancer treatment that involves modifying patients' T-cells to recognize and attack cancer cells. In this therapy, T-cells are collected from the patient, engineered in a lab to express a specific receptor that binds to a protein on cancer cells, and then infused back into the patient to fight the cancer. CAR-T therapies have shown promise in treating certain types of blood cancers, like lymphoma and leukemia.

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.